Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Emily Dexter & Qingzhong Kong. (2021) Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review. Expert Review of Neurotherapeutics 21:9, pages 969-982.
Read now
Read now
Carlo Scialò & Giuseppe Legname. (2020) How would defining Parkinson’s as a prion disease impact the search of a cure?. Expert Review of Neurotherapeutics 20:5, pages 417-420.
Read now
Read now
Articles from other publishers (22)
Tuane C. R. G. Vieira, Caroline A. Barros, Renato Domingues & Tiago Fleming Outeiro. (2023) PrP meets alpha‐synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry.
Crossref
Crossref
Sandesh Neupane, Elena De Cecco & Adriano Aguzzi. (2023) The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates. Journal of Molecular Biology 435:12, pages 167930.
Crossref
Crossref
Anika Adulla, Urvi Patel, Ajay Ashok, Priya Katiyar, Mare Kaulakis, Alexander E. Kritikos, Sachin Pillai, HyunPin Lee, Ewald Lindner, Douglas J. Rhee & Neena Singh. (2023) α-Synuclein modulates fibronectin expression in the trabecular meshwork independent of TGFβ2. Experimental Eye Research 226, pages 109351.
Crossref
Crossref
Izabella Grimaldi, Felipe Saceanu Leser, José Marcos Janeiro, Bárbara Gomes da Rosa, Ana Clara Campanelli, Luciana Romão & Flavia Regina Souza Lima. (2022) The multiple functions of PrPC in physiological, cancer, and neurodegenerative contexts. Journal of Molecular Medicine 100:10, pages 1405-1425.
Crossref
Crossref
Mohsin Shafiq, Stefano Da Vela, Ladan Amin, Neelam Younas, David A. Harris, Inga Zerr, Hermann C. Altmeppen, Dmitri Svergun & Markus Glatzel. (2022) The prion protein and its ligands: Insights into structure-function relationships. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1869:6, pages 119240.
Crossref
Crossref
Valerija Kovač & Vladka Čurin Šerbec. (2022) Prion Protein: The Molecule of Many Forms and Faces. International Journal of Molecular Sciences 23:3, pages 1232.
Crossref
Crossref
Mingmin Yan, Min Xiong, Lijun Dai, Xingyu Zhang, Yunhong Zha, Xiaorong Deng, Zhui Yu & Zhentao Zhang. (2022) Cofilin 1 promotes the pathogenicity and transmission of pathological α-synuclein in mouse models of Parkinson’s disease. npj Parkinson's Disease 8:1.
Crossref
Crossref
Tobias Thom, Matthias Schmitz, Anna‐Lisa Fischer, Angela Correia, Susana Correia, Franc Llorens, Anna‐Villar Pique, Wiebke Möbius, Renato Domingues, Saima Zafar, Erik Stoops, Christopher J. Silva, Andre Fischer, Tiago F. Outeiro & Inga Zerr. (2021) Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Movement Disorders 37:1, pages 39-51.
Crossref
Crossref
Jessica D. Panes, Paulina Saavedra, Benjamin Pineda, Kathleen Escobar, Magdalena E. Cuevas, Gustavo Moraga-Cid, Jorge Fuentealba, Coralia I. Rivas, Human Rezaei & Carola Muñoz-Montesino. (2021) PrPC as a Transducer of Physiological and Pathological Signals. Frontiers in Molecular Neuroscience 14.
Crossref
Crossref
Kurt A. Jellinger, Gregor K. Wenning & Nadia Stefanova. (2021) Is Multiple System Atrophy a Prion-like Disorder?. International Journal of Molecular Sciences 22:18, pages 10093.
Crossref
Crossref
Elena De Cecco, Luigi Celauro, Silvia Vanni, Micaela Grandolfo, Edoardo Bistaffa, Fabio Moda, Adriano Aguzzi & Giuseppe Legname. (2020) The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells. Journal of Neurochemistry 155:5, pages 577-591.
Crossref
Crossref
Bing Leng, Hairong Sun, Junwu Zhao, Yuanyuan Liu, Tengqun Shen, Wenjin Liu, Xiaoxiao Liu, Ming Tan, Fang Li, Jinbiao Zhang & Zhenguang Li. (2020) Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients. Neuroscience Letters 723, pages 134866.
Crossref
Crossref
Rosalina Gavín, Laia Lidón, Isidre Ferrer & José Antonio del Río. (2020) The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain. Cells 9:3, pages 591.
Crossref
Crossref
Naomi P. Visanji, Anthony E. Lang & Gabor G. Kovacs. (2019) Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities. Translational Neurodegeneration 8:1.
Crossref
Crossref
Stefano Thellung, Alessandro Corsaro, Alessia Bosio, Martina Zambito, Federica Barbieri, Michele Mazzanti & Tullio Florio. (2019) Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells. Cells 8:11, pages 1458.
Crossref
Crossref
Kurt A. Jellinger. (2019) Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders. Journal of Neural Transmission 126:8, pages 933-995.
Crossref
Crossref
Jiangnan Ma, Jing Gao, Jing Wang & Anmu Xie. (2019) Prion-Like Mechanisms in Parkinson’s Disease. Frontiers in Neuroscience 13.
Crossref
Crossref
Eftychia Vasili, Antonio Dominguez-Meijide & Tiago Fleming Outeiro. (2019) Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved. Frontiers in Molecular Neuroscience 12.
Crossref
Crossref
Alexei A. Surguchev, Fatemeh Nouri Emamzadeh & Andrei Surguchov. (2019) Cell Responses to Extracellular α-Synuclein. Molecules 24:2, pages 305.
Crossref
Crossref
Inês Caldeira Brás, Luísa V. Lopes & Tiago Fleming Outeiro. (2018) Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration. Movement Disorders 33:11, pages 1675-1684.
Crossref
Crossref
R. N. Mustafin & E. K. Khusnutdinova. (2018) INTERRELATION OF PRIONS WITH NON-CODING RNAS. Vavilov Journal of Genetics and Breeding 22:4, pages 415-424.
Crossref
Crossref
AntoniaN Klein, Erica Corda & Sabine Gilch. (2018) Peptide aptamer-mediated modulation of prion protein α-cleavage as treatment strategy for prion and other neurodegenerative diseases. Neural Regeneration Research 13:12, pages 2108.
Crossref
Crossref